Celcuity (CELC) Change in Accured Expenses (2016 - 2025)
Celcuity (CELC) posted Change in Accured Expenses of $11.1 million for Q4 2025, up 606.79% on a QoQ basis from -$2.2 million in Q3 2025, and up 320.93% year-over-year from $2.6 million in Q4 2024.
Celcuity (CELC) Change in Accured Expenses (2016 - 2025) Analysis & Trends
Celcuity's Change in Accured Expenses history runs 10 years deep, the most recent figure standing at $11.1 million for Q4 2025.
- Quarterly Change in Accured Expenses rose 320.93% year-over-year to $11.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.4 million (up 410.72% YoY) and the FY2025 annual result came in at $15.4 million, up 410.72% from the prior year.
- Change in Accured Expenses was $11.1 million for Q4 2025 at Celcuity, up from -$2.2 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $11.1 million in Q4 2025 and bottomed at -$5.0 million in Q4 2024.
- A 5-year average of $1.3 million and a median of $731978.5 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2021 — Change in Accured Expenses plunged 533.84% — and 2022, when it surged 4232.71%.
- Celcuity's Change in Accured Expenses stood at -$76959.0 in 2021, then surged by 1382.46% to $986965.0 in 2022, then jumped by 106.69% to $2.0 million in 2023, then slumped by 346.82% to -$5.0 million in 2024, then surged by 320.93% to $11.1 million in 2025.
- Business Quant data shows CELC's Change in Accured Expenses at $11.1 million in Q4 2025, -$2.2 million in Q3 2025, and $5.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | 11.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.12 Mn |
| Dec 31, 2025 | 11.12 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Mar 31, 2025 | 633,000.00 |
| Mar 31, 2025 | 633,000.00 |
| Dec 31, 2024 | -5.04 Mn |
| Dec 31, 2024 | -5.04 Mn |
| Sep 30, 2024 | 3.83 Mn |
| Sep 30, 2024 | 3.83 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Sep 30, 2023 | 3.02 Mn |